Your browser doesn't support javascript.
loading
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p.
Berrout, Jonathan; Kyriakopoulou, Eleni; Moparthi, Lavanya; Hogea, Alexandra S; Berrout, Liza; Ivan, Cristina; Lorger, Mihaela; Boyle, John; Peers, Chris; Muench, Stephen; Gomez, Jacobo Elies; Hu, Xin; Hurst, Carolyn; Hall, Thomas; Umamaheswaran, Sujanitha; Wesley, Laura; Gagea, Mihai; Shires, Michael; Manfield, Iain; Knowles, Margaret A; Davies, Simon; Suhling, Klaus; Gonzalez, Yurema Teijeiro; Carragher, Neil; Macleod, Kenneth; Abbott, N Joan; Calin, George A; Gamper, Nikita; Zygmunt, Peter M; Timsah, Zahra.
Afiliación
  • Berrout J; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Kyriakopoulou E; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Moparthi L; Division of Clinical Chemistry and Pharmacology, Lund University, 221 85, Lund, Sweden.
  • Hogea AS; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK.
  • Berrout L; The University of Texas at Brownsville, Brownsville, TX, 78520, USA.
  • Ivan C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
  • Lorger M; Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, LS9 7TF, Leeds, UK.
  • Boyle J; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK.
  • Peers C; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK.
  • Muench S; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK.
  • Gomez JE; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK.
  • Hu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
  • Hurst C; Faculty of Medicine and Health, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS2 9JT, UK.
  • Hall T; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Umamaheswaran S; Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, 600025, India.
  • Wesley L; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Unit 63, Houston, TX, 77054, USA.
  • Shires M; Section of Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, UK.
  • Manfield I; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Knowles MA; Faculty of Medicine and Health, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS2 9JT, UK.
  • Davies S; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK.
  • Suhling K; Department of Physics, King's College London, Strand, London, WC2R 2LS, UK.
  • Gonzalez YT; Department of Physics, King's College London, Strand, London, WC2R 2LS, UK.
  • Carragher N; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
  • Macleod K; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK.
  • Abbott NJ; Institute of Pharmaceutical Science, Franklin-Wilkins Building, King's College London, London, SE1 9NH, UK.
  • Calin GA; Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.
  • Gamper N; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK.
  • Zygmunt PM; Division of Clinical Chemistry and Pharmacology, Lund University, 221 85, Lund, Sweden.
  • Timsah Z; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK. Z.Timsah@leeds.ac.uk.
Nat Commun ; 8(1): 947, 2017 10 16.
Article en En | MEDLINE | ID: mdl-29038531
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncogenes / MicroARNs / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos / Canal Catiónico TRPA1 Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncogenes / MicroARNs / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos / Canal Catiónico TRPA1 Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido